Published on: Aug 25, 2017 at Practice Update

Sequential Ipilimumab Monotherapy vs Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

By : Practice Update

A recent study looked into sequential Ipilimumab monotherapy for unresectable locally advanced gastric cancer. It found ipilimumab was manageable but did not show improvements over best supportive care. However, the study supports investigation of ipilimumab in combination with other therapies.

Read More
SHARE